首页> 外文期刊>Peptides: An International Journal >Characterization of (125I)AR-M100613, a high-affinity radioligand for delta opioid receptors.
【24h】

Characterization of (125I)AR-M100613, a high-affinity radioligand for delta opioid receptors.

机译:(125I)AR-M100613的特征,一种用于δ阿片受体的高亲和力放射性配体。

获取原文
获取原文并翻译 | 示例
       

摘要

AR-M100613 ([I]-Dmt-c[-D-Orn-2-Nal-D-Pro-D-Ala-]) is the iodinated analog of a cyclic casomorphin previously shown to be a potent antagonist at the delta opioid receptor. Specific [125I]AR-M100613 binding to rat whole brain membranes was saturable, reversible, and best fit to a one-site model (Kd = 0.080 +/- 0.008 nM, Bmax = 45.2 +/- 4.4 fmol/mg protein). [125I]AR-M100613 binding was displaced with high affinity by the delta opioid receptor ligands SNC-80, Deltorphin II and DPDPE but not the mu or kappa-selective receptor ligands DAMGO and U69593. Residual non-selective binding of [125I]AR-M 100613 to mu opioid receptors is blocked by the addition of CTOP to the assay buffer. [35S]GTPgammaS binding assays indicate that AR-M100613 is a potent, selective, and reversible antagonist for delta opioid receptors in rat brain membranes. The high-affinity, high specific activity, low nonspecific binding and antagonist profile of [125I]AR-M100613 favor its use as a radiochemical probe for delta opioid receptors.
机译:AR-M100613([I] -Dmt-c [-D-Orn-2-Nal-D-Pro-D-Ala-])是环状casomorphin的碘化类似物,以前被证明是δ阿片类药物的强效拮抗剂受体。与大鼠全脑膜的特异性[125I] AR-M100613结合是可饱和的,可逆的,并且最适合单点模型(Kd = 0.080 +/- 0.008 nM,Bmax = 45.2 +/- 4.4 fmol / mg蛋白)。 [125I] AR-M100613的结合被δ阿片受体配体SNC-80,德尔托芬II和DPDPE高亲和力取代,但对μ或κ选择性受体配体DAMGO和U69593却没有。通过向测定缓冲液中添加CTOP,可以阻止[125I] AR-M 100613与μ阿片类药物受体的残留非选择性结合。 [35S] GTPgammaS结合测定表明,AR-M100613是大鼠脑膜中δ阿片受体的有效,选择性和可逆拮抗剂。 [125I] AR-M100613的高亲和力,高比活性,低非特异性结合和拮抗剂特性有利于将其用作δ阿片受体的放射化学探针。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号